QM

QMS Medical Allied Services Ltd

Q3 FY26Healthcare Equipment & Supplies

QMS Medical Allied Services Q3 FY26: Revenue ₹37.3 Cr, PAT ₹3.2 Cr

Q3 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹171
Market cap₹330 Cr
P/E30.7
Updated16 Oct 2026
Read4 min read

Based on QMS Medical Allied Services Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentationreports, not management guidance.

The short version

Q3FY26 Revenue from Operations: ₹37.3 crore - Q3FY25 Revenue from Operations: ₹43.9 crore - Year-on-Year (YoY) change in Q3 Revenue: -15% - 9MFY26 Revenue: ₹128.5 crore (15% YoY increase over 9MFY25) - No explicit quarterly volume or sales unit figures are provided. Q3FY26 EBITDA: ₹6.7 Cr, down 3% YoY (Q3FY25 EBITDA: ₹6.9 Cr) - Q3FY26 EBITDA Margin: 18.1%, up from 15.8% YoY - Q3FY26 PAT: ₹3.2 Cr, down 8% YoY (Q3FY25 PAT: ₹3.5 Cr) - Q3FY26 PAT Margin: 8.5%, up from 7.9% YoY - No explicit overall operating margin figure stated for the quarter, but gross profit margin is 49.4% (Q3FY26) vs.

From QMS Medical Allied Services Ltd's Q3 FY26 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

  • Q3FY26 Revenue from Operations: ₹37.3 crore
  • Q3FY25 Revenue from Operations: ₹43.9 crore
  • Year-on-Year (YoY) change in Q3 Revenue: -15%
  • 9MFY26 Revenue: ₹128.5 crore (15% YoY increase over 9MFY25)

2 more points from QMS Medical Allied Services Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what QMS Medical Allied Services Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The investor presentation does not explicitly describe any capex, capacity expansion, or new plant/project details including amounts, status, or timelines. The documents focus on financial performance, business strategy, product and service offerings, technology platforms, and growth drivers without specifying any capital expenditure plans or new facility developments. No direct mention is made of ongoing or planned expansions or projects with associated investments or timelines.

Top-ranked in Healthcare Equipment & Supplies

Ranked on what management guided this quarter

Guidance-ranked
1Molbio Diagnosti
Rev 2Mar 3
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what QMS Medical Allied Services Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report any figures or information related to order book, order inflow, or pending orders. There is no mention or data provided concerning: - Current order book size - Order inflow rates - Pending or outstanding orders The presentation predominantly focuses on financial performance, business offerings, patient support programs, consolidated financials, revenue, EBITDA, and operational highlights, without detailing order backlog or order flow metrics.

QMS Medical Allied Services Ltd — Quarterly revenue & net profit

Revenue Net profit
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹37 Cr, net profit ₹3 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Equipment & Supplies this season

  • Tarsons Products Ltd (Q3 FY26)

    Tarsons has undertaken a significant capex of INR 600 crores announced in 2021-22, with partial commercialization in 2026. Key concall takeaways from Tarsons…

  • Laxmi Dental Ltd (Q3 FY26)

    Scanner sales growth to continue, with digital penetration in India planned to increase from 79% to 90%, driving future expansion. Key concall takeaways from…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

QMS Medical Allied Services Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were QMS Medical Allied Services Ltd Q3 FY26 results?

Q3FY26 Revenue from Operations: ₹37.3 crore - Q3FY25 Revenue from Operations: ₹43.9 crore - Year-on-Year (YoY) change in Q3 Revenue: -15% - 9MFY26 Revenue: ₹128.5 crore (15% YoY increase over 9MFY25) - No explicit quarterly volume or sales unit figures are provided. Q3FY26 EBITDA: ₹6.7 Cr, down 3% YoY (Q3FY25 EBITDA: ₹6.9 Cr) - Q3FY26 EBITDA Margin: 18.1%, up from 15.8% YoY - Q3FY26 PAT: ₹3.2 Cr, down 8% YoY (Q3FY25 PAT: ₹3.5 Cr) - Q3FY26 PAT Margin: 8.5%, up from 7.9% YoY - No explicit overall operating margin figure stated for the quarter, but gross profit margin is 49.4% (Q3FY26) vs.

What is QMS Medical Allied Services Ltd share price analysis?

QMS Medical Allied Services Ltd currently shows a neutral. The stock trades at a P/E of 30.7 with a market cap of ₹330 Cr. Investors should review the full earnings analysis for detailed insights.

Is QMS Medical Allied Services Ltd planning capital expenditure?

The investor presentation does not explicitly describe any capex, capacity expansion, or new plant/project details including amounts, status, or timelines.

Keep QMS Medical Allied Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.